Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sristi Jayaswal

Is Wall Street Bullish or Bearish on Regeneron Pharmaceuticals Stock?

Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company has a market capitalization of $83.7 billion and develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases, as well as cancer and more.

The company's shares have outperformed the broader market over the past year and in 2026. REGN stock has surged 14.1% over the past 52 weeks and 1.4% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 11.7% over the past year and grown marginally in 2026.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.